Growing Market Presence Eko Health's recognition on TIME's 2025 World's Top HealthTech Companies list and recent partnerships with digital health leaders like Impilo and The Digital Health Store highlight its expanding influence and opportunities to collaborate with enterprise clients and health system providers.

Innovative Product Portfolio The award-winning CORE 500 digital stethoscope and the launch of a fully web-based platform with SSO support demonstrate Eko's commitment to cutting-edge, user-friendly technology, presenting opportunities to upsell or integrate with healthcare providers seeking advanced diagnostic tools.

Strong Industry Reputation With over 650,000 devices sold globally and high-profile endorsements, Eko Health's reputation for reliable, AI-powered cardiac and pulmonary detection positions it as a trusted partner for hospitals, clinics, and medical device distributors aiming to enhance their diagnostic capabilities.

Funding and Growth Potential Having secured $41 million in funding and generating between $25 million and $50 million in revenue, Eko Health is in a strong financial position with growth potential, making it a viable partner for strategic collaborations and sales expansion within the healthcare industry.

Strategic Innovation and Recognition The company's recent awards and high-profile medical advisory appointments, including Jerome Adams, augment its credibility and innovation trajectory, providing a compelling reason for healthcare organizations to adopt Eko's digital health solutions to improve patient outcomes.